Skip to main content
TipRanks
Go Ultimate75% OFF

Henry Schein (0L3C) Share Price & Analysis

0 Followers

0L3C Stock Chart & Stats

$87.70-$1.69(-1.90%)
At close: 4:30 PM GMT
$82.5$85$87.5$90Aug 17Aug 31Sep 14Sep 28Oct 12Oct 27Nov 9
Day’s Range
$87.25 - $87.70
52-Week Range
$68.33 - $92.50
Previous Close
$89.40
Volume
N/A
Average Volume (3M)
115
Market Cap
$9.81B
Enterprise Value
$15.00B
Total Cash (Recent Filing)
$184.00M
Total Debt (Recent Filing)
$3.89B
Price to Earnings (P/E)
24.0
Beta
0.84
Next Earnings
Mar 02, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Dental Share Gains

Strong U.S. dental merchandise growth reflects volume gains and expanding customer penetration in a stable market. Increasing share among private practices and emerging DSOs, alongside greater share of wallet, supports durable revenue growth and reinforces Henry Schein’s distribution position.

Technology Platform Expansion

Growing adoption of cloud practice-management platforms creates a recurring technology revenue base alongside distribution sales. AI-enabled workflows, claims, collections, and clinical tools can deepen customer relationships, raise switching costs, and support longer-term mix improvement.

Improving Earnings Outlook

Raised earnings guidance and expected high-single-digit EBITDA growth indicate that portfolio initiatives and operating improvements are translating into stronger profitability. The stated plan for over $200 million of operating-income improvement provides a multi-quarter framework for margin expansion.

Bears Say

Higher Leverage

The substantial increase in leverage reduces financial flexibility compared with prior years and makes the business more sensitive to interest costs or operating setbacks. It may also constrain the capacity to fund acquisitions, repurchases, and growth initiatives internally.

Weaker Free Cash Flow Trend

Henry Schein continues to generate meaningful cash, but the recent decline in free cash flow and modest cash flow relative to debt weaken debt-reduction capacity. If this trend persists, less internally generated cash will be available for investment and capital allocation.

Thin Profitability And Category Pressure

A relatively thin net margin leaves limited room to absorb cost, mix, or demand pressure. Current weakness in discretionary dental procedures, diagnostics, and vaccines adds uncertainty to the lower-margin medical and consumer-sensitive portions of the portfolio, potentially limiting earnings leverage.

Henry Schein News

0L3C FAQ

What was Henry Schein’s price range in the past 12 months?
Henry Schein lowest share price was $68.33 and its highest was $92.50 in the past 12 months.
What is Henry Schein’s market cap?
Henry Schein’s market cap is $9.81B.
When is Henry Schein’s upcoming earnings report date?
Henry Schein’s next earnings report is estimated for Mar 02, 2027 (not yet confirmed), which is in 109 days.
How were Henry Schein’s earnings last quarter?
Henry Schein released its earnings results on Nov 03, 2026. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.361 by $0.199.
Is Henry Schein overvalued?
According to Wall Street analysts Henry Schein’s price is currently Undervalued.
Does Henry Schein pay dividends?
Henry Schein does not currently pay dividends.
What is Henry Schein’s EPS estimate?
Henry Schein’s EPS estimate is 1.41.
How many shares outstanding does Henry Schein have?
Henry Schein has 110,538,540 shares outstanding.
What happened to Henry Schein’s price movement after its last earnings report?
Henry Schein reported an EPS of $1.56 in its last earnings report, beating expectations of $1.361. Following the earnings report the stock price went down -4.896%.
Which hedge fund is a major shareholder of Henry Schein?
Hedge funds hold Henry Schein shares: the largest hedge-fund position in Henry Schein is 720,912,616 shares, and hedge funds increased their holdings by 81.2K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology